Peripheral oxidative stress markers in diabetes-related dementia

Geriatrics and Gerontology International

Volumn 16, Issue 12, 2016, Pages 1312-1318

  Hatanaka, Hirokuni ^a   Hanyu, Haruo ^a   Fukasawa, Raita ^a   Sato, Tomohiko ^a   Shimizu, Soichiro ^a   Sakurai, Hirofumi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; anti oxidants; diabetes mellitus; diabetes related dementia; oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; ALBUMIN; APOLIPOPROTEIN E4; BILIRUBIN; HEMOGLOBIN A1C; URIC ACID; 8-OXO-7-HYDRODEOXYGUANOSINE; BIOLOGICAL MARKER; DEOXYGUANOSINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DIABETES RELATED DEMENTIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSLIPIDEMIA; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PARIETOTEMPORAL LOBE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TEMPORAL LOBE; ANALOGS AND DERIVATIVES; DIABETIC COMPLICATION; URINE;

AGED; ALZHEIMER DISEASE; BIOMARKERS; DEMENTIA; DEOXYGUANOSINE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; MALE; OXIDATIVE STRESS;

EID: 84965111453     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12645     Document Type: Article

References (31)

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systemic review. Lancet Neurol 2006; 5: 64–74.
2. Fukazawa R, Hanyu H, Sato T et al. Subgroups of Alzheimer's disease associated with diabetes mellitus based on brain imaging. Dement Geriatr Cogn Disord 2013; 35: 280–290.
3. Bonte FJ, Harris TS, Hynan LS, Bigio EH, White CL III. Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation. Clin Nucl Med 2006; 31: 376–378.
4. Fukasawa R, Hanyu H, Shimizu S, Kanetaka H, Sakurai H, Ishii K. Identification of diabetes-related dementia: longitudinal perfusion SPECT and amyloid PET studies. J Neurol Sci 2015; 349: 45–451.
5. Hanyu H, Hirose D, Fukasawa R, Hatanaka H, Namioka N, Sakurai H. Guidelines for the clinical diagnosis of diabetes-related dementia. J Am Geriatr Soc 2015; 63: 1721–1723.
6. Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 2007; 85: 3036–3040.
7. Phhanka M. Alzheimer's disease and oxidative stress: a review. Curr Med Chem 2014; 21: 356–364.
8. Maritim AC, Sanders RA, Watkins JB III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2001; 17: 24–38.
9. Yang H, Jin X, Kei Lam CW, Yan SK. Oxidative stress and diabetes mellitus. Clin Chem Lab Med 2011; 49: 1773–1782.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939–944.
11. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987; 149: 351–356.
12. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1965; 12: 189–198.
13. Schrag M, Mueller C, Zabel M et al. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiol Dis 2013; 59: 100–110.
14. Skoumalova A, Hort J. Blood markers of oxidative stress in Alzheimer's disease. J Cell Mol Med 2012; 16: 2291–2300.
15. Torres LL, Quaglio NB, de Souza GT et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011; 26: 59–68.
16. Kim TS, Pae CU, Yoon SY et al. Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2006; 21: 344–348.
17. Cankurtaran M, Yesil Y, Kuyumcu E et al. Altered levels of homocystein and serum natural antioxidants links oxidative damage to Alzheimer's disease. J Alzheimers Dis 2013; 33: 1051–1058.
18. Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci 1994; 54: 477–481.
19. Takahashi M, Sugiyama K, Shumiya S, Nagase S. Penetration of bilirubin into the brain in albumin-deficient and jaundiced rats (AJR) and Nagase analbuminemic rats (NAR). J Biochem 1984; 96: 1705–1712.
20. Cheriyath P, Gorrepati VS, Peters I et al. High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999–2006. J Clin Med Res 2010; 2: 201–206.
21. Lv Q, Meng XF, He FF et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS ONE 2013; 8: e56864.
22. Bandaru P, Shankar A. Association between serum uric acid levels and diabetes mellitus. Int J Endocrinol 2011; 604715. doi: 10.1155/2011/604715.
23. Zengi O, Karakas A, Ergun U, Senes M, Inan L, Yucel D. Urinary 8-hydroxy-2'-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease. Clin Chem Lab Med 2011; 50: 529–534.
24. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetes. Clin Chim Acta 2004; 339: 1–9.
25. Tuppo EE, Forman LJ, Spur BW, Chan-Ting RE, Chopra A, Cavalieri TA. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease. Brain Res Bull 2001; 54: 565–568.
26. Mezzetti A, Cipollone F, Cuccurullo F. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc Res 2000; 47: 475–488.
27. Fukazawa R, Hanyu H, Namioka N, Hatanaka H, Sato T, Sakurai H. Elevated inflammatory markers in diabetes-related dementia. Geriatr Gerontol Int 2014; 14: 229–231.
28. Calkin AC, Giunti S, Sheehy KJ et al. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation. Diabetologia 2008; 51: 1731–1740.
29. Melo JB, Sousa C, Garcao P, Oliveria CR, Agostinho P. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons. Eur J Neurosci 2009; 29: 455–464.
30. Farrall AJ, Wardlaw JW. Blood-brain barrier: ageing and microvascular disease – systemic review and meta-analysis. Neurobiol Aging 2009; 30: 337–352.
31. 2α-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann Neurol 2000; 48: 809–812.